公开(公告)号：US20180211722A1

公开(公告)日：2018-07-26

申请号：US15877726

申请日：2018-01-23

Applicant: BOSTON HEART DIAGNOSTICS CORPORATION

Inventor： Michael Dansinger ,  Michael Riel-Mehan ,  Julia Maddalena

IPC: G16H20/17 ,  G06F19/26 ,  G16H50/50

CPC classification number: G16H20/17 ,  G16B45/00 ,  G16H20/10 ,  G16H50/30 ,  G16H50/50

Abstract: An insulin activity map is a tool for assessing a patient's metabolic risk, designing a treatment plan, disseminating the information in a useful way to the patient, and encouraging the patient to remain on a treatment course. The insulin activity map combines a variety of inputs such as insulin sensitivity and insulin production to generate a patient-specific diagnosis and treatment assessment. The insulin activity map fills an important gap in prior art testing methods, providing diagnostic insights that improve clinician and patient understanding of the progression of diabetes, allows at-risk patients to more easily avoid developing diabetes, and helps diabetic and prediabetic patients manage and control the disease.